Class III · Lower riskRecall completed
Enalapril Maleate Tablets USP; 2.5 mg NDC code 64679-923-03. 1000 Tablets HDPE c
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberBatch# DR10447 (Exp: 4/19); Batch# DR10996 (Exp: 10/19); Batch# DS10201 (Exp: 2/20); and Batch# DR10319 (Exp: 3/20).
Where it was soldNationwide.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed Impurities/Degradation Specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Wockhardt Limited |
Show the full FDA record
| Full product label | Enalapril Maleate Tablets USP; 2.5 mg NDC code 64679-923-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons. |
| Recalling firm | Wockhardt Limited |
| Distribution | Nationwide. |
| Quantity | 17,628 tablets |
| Recall initiated | 2018-06-19 |
| Report date | 2018-07-18 |
| Recall completed | 2020-04-13 |
| Recall number | D-0913-2018 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Karodi India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.